sprodiamide has been researched along with Injury, Myocardial Reperfusion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Derugin, N; Geschwind, JF; Higgins, CB; Lauerma, K; Saeed, M; Wendland, MF | 1 |
| Arteaga, C; Canet, E; Forrat, R; Hadour, G; Oksendal, A; Revel, D; Zhao, S | 1 |
| Higgins, CB; Saeed, M; Wendland, MF | 1 |
3 other study(ies) available for sprodiamide and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
AUR Memorial Award. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging.
Topics: Animals; Awards and Prizes; Cell Death; Contrast Media; Drug Evaluation, Preclinical; Dysprosium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organometallic Compounds; Pentetic Acid; Rats; Rats, Sprague-Dawley | 1994 |
Myocardial "low reflow" assessed by Dy-DTPA-BMA-enhanced first-pass MR imaging in a dog model.
Topics: Animals; Contrast Media; Coronary Circulation; Dogs; Dysprosium; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid | 1999 |
Characterization of reperfused myocardial infarctions with T1-enhancing and magnetic susceptibility-enhancing contrast media.
Topics: Animals; Contrast Media; Diagnosis, Differential; Drug Evaluation, Preclinical; Dysprosium; Gadolinium; Gadolinium DTPA; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Reperfusion Injury; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |